Introduction
============

Compared to Europeans, Africans frequently show signs of chronic immune activation of peripheral blood T-cells [@B7]. Recently, we assessed the distribution of T-cell maturation phenotypes in a population living in Nouna, rural Burkina Faso [@B5] and observed significantly lower proportions of CD45RA^bright^CCR7^pos^naive Tcells in healthy adults compared to published data from France [@B20]. Such a skewed distribution of T-cell maturation phenotypes may be a consequence of chronic immune activation. Exposure to *Plasmodium falciparum*, the causative agent of malaria in that area, may be a driving force behind chronic immune activation. However, the ability of the parasite to induce long-lasting T-cell immunity has long been questioned [@B1][@B21]. We therefore screened the population in Nouna during the dry season for the presence of peripheral blood T-cells specifically recognizing *Plasmodium falciparum*merozoite surface protein-1 (P*f*MSP1), a surface protein expressed during the parasite\'s blood stage [@B9].

The immune response against *Plasmodium falciparum*blood-stage components is centrally mediated by interferon-gamma ( IFN-γ), which is produced predominantly by CD4^+^effector memory T-cells [@B12]. Antigen-dependent release of IFN-γ has been shown to up-regulate the Fas-receptor (CD95) on bystander cells [@B15]. CD95-expression on human CD4^+^T-cells was characterized by a bimodal distribution showing two peaks, i.e., CD95^dim^and CD95^bright^[@B6]. We had shown in the past by magnetic bead isolation and 3-color flow cytometry [@B2] and by 4-color flow cytometry [@B6] that the cell populations constituting the CD95^dim^and the CD95^bright^peak of CD4^+^T-cells correspond to resting naïve and activated memory cells, respectively. We therefore performed a second study consisting in a direct comparison of CD95 expression levels on T-cells in peripheral blood of healthy adults in Burkina Faso and healthy subjects living in Germany. Our results indicate that differences in the dynamics of T-cell maturation as well as in levels of T-cell activation between Burkina Faso and Germany may be caused by differences in the exposure to *Plasmodium falciparum*.

Material
========

Nouna is situated in North West Burkina Faso near the Malian border. Malaria transmission is high during the rainy season between July and November and very little transmission occurs at other times of the year [@B16]. Approximately 6 months after the malaria season in May and June 2005 peripheral blood from healthy male and female blood donors was screened for the presence of P*f*MSP-1 -specific CD4^+^lymphocytes during a blood donation campaign in Nouna. The study was part of a population-based study which was undertaken to generate site- and gender-specific reference values for immunohematological parameters in healthy adults. It was approved by the Institutional Ethics Committees of the University of Heidelberg, Germany, and of the Nouna Health Research Centre, Burkina Faso [@B11].

All donors received a clinical examination and all blood samples were tested for infection with HIV (Determine and Genie II, Abbott Laboratories, Wiesbaden, Germany), HBV (Bioline HBsAg Rapid Test Kit, Standard Diagnostics, Kyonggi-Do, Korea) and syphilis (RPR 100, Newmarket Laboratories, Suffolk, UK). In 17 healthy donors (5 male and 12 female) with a median age of 32 years (range, 17 to 43) the frequency of P*f*MSP-1-specific CD4^+^lymphocytes was assessed. All participants were local residents with lifelong exposure to *Plasmodium falciparum*not showing clinical signs of acute malaria. During preliminary experiments on peripheral blood from 4 healthy adults in Heidelberg no P*f*MSP-1-specific CD4^+^lymphocytes had been detected.

Participants of the follow-up study were recruited between September 2008 and February 2009 from students and employees at the Medical Faculty of the University of Heidelberg in Germany (Heidelberg, n = 20), the Centre Hôpitalier Universitaire Yalgado Ouedraogo (CHUYO, Ouagadougou, n = 20), and the Centre de Recherche en Santé de Nouna (CRSN, Nouna, n = 20) in Burkina Faso. All subjects had a negative HIV test and no clinical signs of illness. Both the national ethics committee in Burkina Faso and the institutional ethics committee at the University of Heidelberg had approved the study protocol. CHUYO is situated in the urban area of Ouagadougou, the capital city of Burkina Faso, West-Africa.

Methods and statistics
======================

Samples from Heidelberg were analyzed on a standard FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA) equipped with two laser sources, samples from Ouagadougou on a FACSCalibur (BD Biosciences) with only one laser source, and samples from Nouna on a standard single laser FACScan flow cytometer (BD Biosciences). CaliBrite beads (BD Biosciences) were used to set the instrument on a regular basis. Instrument settings were controlled longitudinally and remained constant during the study. Data acquisition for immunophenotyping peripheral blood T-cells was stopped manually when at least 10,000 events were counted in the predefined gate. Data acquisition for the lymphocyte activation assay was not stopped manually; instead, usually, the whole blood sample was acquired in order to increase the amount of analyzable CD4^+^T-cells (see below). List mode data from all samples were analyzed using the CellQuest Pro software version 5.2 (BD Biosciences).

CD4^+^and CD8^+^naïve and memory lymphocyte subsets were assessed with anti-CD4- or anti-CD8-PerCP, anti-CD45RA-FITC and anti-CCR7-PE conjugated monoclonal antibodies as described [@B5]. In order to allow pooled analysis of list mode data obtained on different flow cytometers in the three different study sites, a pattern recognition approach based on the recognition of the cell population clearly identifiable as CD45RA^bright^CCR7^pos^naïve T-cells [@B19] was used to define the position of the quadrant marker distinguishing different T-cell maturation phenotypes. Compared to our original analysis [@B5], this approach led to an overestimation of the CD45RA^low^CCR7^pos^central memory subpopulation and an underestimation of CD45RA^bright^CCR7^neg^effector memory cells, but avoided a fixed setting of the border between CD45RA^low^and CD45RA^bright^or between CCR7^neg^and CCR7^pos^cells, which would be influenced by differences in FCM settings (e.g., different photomultiplier voltages). The proportion of naïve T-cells was not affected by the differences between both methods of analyzing list mode data.

T-cell activation was determined with anti-CD95-PE, anti-CD3-PerCP and anti-CD4-FITC to assess the expression of CD95 on CD4^+^T-cells, and anti-CD38-PE, anti-CD3-PerCP and anti-CD8-FITC to assess the expression of CD38 on CD8^+^T-cells (Figure [1](#F1){ref-type="fig"}). The autofluorescence of an unstained lymphocyte sample of each subject was used as determinator of the marker threshold for CD95^+^or CD38^+^cells in the histogram plot. Previous experiments had shown that unstained samples and samples incubated with PE-conjugated highly purified isotype control antibodies (BD Biosciences) had identical fluorescence intensities in the FL-2 histogram curves, allowing us to skip isotype control antibodies completely. The marker indicating positivity was set in order to include less than 2% of unstained lymphocytes.

![**Assessment of T-cell activation in healthy adults living in Nouna, Burkina Faso (A and B) or Heidelberg, Germany (C and D)**. Blood samples were stained with anti-CD3-PerCP, anti-CD4-FITC, and anti-CD95-PE (A and C) or anti-CD3-PerCP, anti-CD8-FITC, and anti-CD38-PE (B and D). CD3^+^lymphocytes were identified as having low side-scatter characteristics (SSC-Height) with a high staining intensity in the FL3 channel (CD3-PerCP). Panel A and C: Expression of CD95 on CD4^+^Tcells showed two distinct populations with different CD95 expression levels (peak 1 = CD4^+^CD95^dim^, peak 2 = CD4^+^CD95^bright^). Panel B and D: Expression of CD38 on CD8^+^T-cells was characterized by a single peak on a broad distribution curve of single cell fluorescence intensities. In each histogram plot a marker spanning the region beyond the unstained control signal was used to determine the percentage of marker-positive cells. The median fluorescence intensity (MFI) of each peak representing a specific cell population as well as the median autofluorescence intensity of unstained control cells (MFI-C) was determined using a specific histogram marker positioned over the histogram curve of the population of interest.](2047-783X-16-12-519-1){#F1}

For determination of the median fluorescence intensity (MFI) of CD95 and CD38 on T-cells, specific T-cell subpopulations were identified by histogram markers as shown in Figure [1](#F1){ref-type="fig"}. CD95-expression on human CD4^+^T-cells was assessed as described, i.e., analyzing CD95^dim^and CD95^bright^T-cell subpopulations separately [@B6]. The expression of CD38 on CD8^+^T-cells was characterized by a single unimodal distribution curve in the histogram [@B17]. The histogram marker was set to include the CD38^bright^cell population which has been shown to be of potential clinical interest [@B22]. The QuantiBrite test kit (BD Biosciences) was used in all experiments to convert MFI values into antibody-binding capacity (ABC) per cell according to the instructions of the manufacturer. Since calibration curves were generated on each instrument at each site separately using the same batch of QuantiBrite beads, the resulting numerical ABC values were not influenced by the different FCM settings.

The *ex vivo*short term lymphocyte activation assay was performed essentially as described [@B4]. Peripheral blood lymphocytes were stimulated with full length P*f*MSP-1 [@B10] at a concentration of 50 μg/ml and CD4^+^lymphocytes producing IFN-γ, interleukin-2 (IL-2), or tumor necrosis factor-alpha (TNF-α) were quantified using immunophenotyping and three-colour flow cytometry (Figure [2](#F2){ref-type="fig"}). The superantigen Staphylococcal Enterotoxin B (SEB; Sigma-Aldrich, St. Louis, MO, USA) was used at a concentration of 5 μg/ml as a positive control to ensure responsiveness of peripheral blood T cells. Cells were stimulated for 9 hours at 37°C, during the last 4 hours the intracellular secretion inhibitor Brefeldin A (BD Biosciences) was added at a concentration of 10 μg/ml. A negative control (cells and co-stimulatory antibodies against CD28 and CD49d, both from BD Biosciences) was included to determine spontaneous production of cytokines.

![**Detection of *Plasmodium falciparum*merozoite surface protein-1 (MSP-1)-specific CD4^+^T-cells in a healthy adult living in Nouna, Burkina Faso using the Fastlmmune short term lymphocyte activation assay**. The columns starting from the left depict results obtained with highly purified IgG isotype control antibodies, or antibodies against interferon gamma (IFN-γ), interleukin-2 (IL-2), and tumor necrosis factor-alpha (TNF-α). The upper row shows the unstimulated control sample (US), the middle row the positive control sample stimulated with Staphylococcal Enerotoxin B (SEB) and the lower row the sample stimulated with MSP-1. In the upper left quadrant of each dot plot the number of acquired events in the CD4^+^lymphocyte gate is indicated. In the upper right quadrant the percentage of cytokine-producing cells is shown.](2047-783X-16-12-519-2){#F2}

The statistical significance of the difference between the number of cytokine-producing CD4^+^lymphocytes after antigen stimulation and the corresponding unstimulated control was tested using the following calculation:

$$\textsf{N} = 2^{*}{\textsf{p}_{\textsf{av}}}^{*}\left( {1 - \textsf{p}_{\textsf{av}}} \right)^{*}8,6/\Delta^{2},$$

where Δ^2^= (% cytokine specific CD4^+^lymphocytes in unstimulated control)/100 - (% cytokine specific CD4^+^lymphocytes in antigen stimulation)/100, p~av~= ((% cytokine specific CD4^+^lymphocytes in unstimulated control)/100 + (% cytokine specific CD4^+^lymphocytes antigen stimulation)/100)/2, and N is the necessary number of acquired cells needed for a statistical significance of p \< 0,05 with a statistical power of 90%. If the number of acquired CD4^+^lymphocytes was higher than N, the cytokine production was considered positive.

Mean values, percentiles and standard deviations were calculated for each variable using the GraphPad Prism version 5.00 (Graph Pad Inc., San Diego, CA, USA). Differences between subjects from different sites were analyzed using the non-parametric Mann-Whitney U-test, p-values \< 0.05 indicated statistical significance.

Results
=======

Among 17 healthy HIV-1-negative adults, 14 responded to *Pf*MSP-1 producing at least one of the measured cytokines ( IFN-γ, IL-2, TNF-α; see Table [1](#T1){ref-type="table"}). Of the 14 healthy controls who showed a significant response to *Pf*MSP-1, seven produced all three cytokines. Three subjects produced IFN-γ and TNF-α, 4 subjects IFN-γ alone. Single production of IL-2 or TNF-α could not be detected upon stimulation with P*f*MSP-1. The median percentage of *Pf*MSP-1-specific cytokine-positive CD4^+^lymphocytes was 0.21% (range, 0.06 to 0.77%) for \'IFN-γ, 0.16% (0.06 to 0.39%) for TNF-α and 0.14% (0.04 to 0.26%) for IL-2. The percentage of P*f*MSP-1-specific IFN-γ^+^CD4^+^lymphocytes was higher in healthy controls producing all three cytokines (range, 0.16 to 0,77%) than in those with single production of IFN-γ (range, 0.05 to 0.14%).

###### 

Cytokines produced upon ex vivo stimulation with *Plasmodium falciparum*merozoite surface protein-1 (PfMSP-1) by CD4^+^lymphocytes in healthy adults living in Nouna, Burkina Faso

  **Identification No**.   Interferon-γ   Interleukm-2   Tumor necrosis factor α
  ------------------------ -------------- -------------- -------------------------
  CTRL21                   0.14           n.s.           0.06
  CTRL23                   n.s.           n.s.           n.s.
  CTRL33                   0.16           0.09           0.19
  CTRL36                   n.s.           n.s.           n.s.
  CTRL37                   0.14           n.s.           0.12
  CTRL38                   0.17           0.04           0.07
  CTRL41                   0.31           0.23           0.35
  CTRL53                   0.05           n.s.           n.s.
  CTRL55                   0.34           0.14           0.07
  CTRL56                   0.14           n.s.           0.15
  CTRL57                   0.24           0.10           0.10
  CTRL60                   0.09           n.s.           n.s.
  CTRL61                   0.12           n.s.           n.s.
  CTRL62                   0.77           0.26           0.39
  CTRL65                   0.06           n.s.           n.s.
  CTRL66                   n.s.           n.s.           n.s.
  CTRL67                   0.25           0.14           0.12

Data are shown as per cent of total CD4^+^cells in the lymphocyte gate. In 4 healthy controls from Heidelberg, Germany, no P*f*MSP-1-specific CD4+ lymphocytes were detected (data not shown). Abbreviations: n.s. = not significant.

Compared to Germans, Burkinabe showed markedly lower proportions of CCR7^+^CD45RA^+^naïve CD4^+^cells. No such differences were seen in the CD8^+^T-cell compartment (Table [2](#T2){ref-type="table"}). There was a tendency towards higher frequencies of CD95^+^CD4^+^T-cells and of CD38^+^CD8^+^T-cells in Burkinabé compared to Germans (Table [2](#T2){ref-type="table"}). The median ABC of CD4^+^CD95^dim^cells in Burkinabé was more than twice the value observed in Germans (263 vs. 108, p \< 0.0001). In contrast, no significant differences between both groups were seen regarding the median ABC levels of CD95 on CD4^+^CD95^bright^memory T-cells or of CD38 on CD38^bright^CD8+ T-cells.

###### 

Comparison of clinical and immunological parameters between healthy adults in Burkina Faso and Germany

                                                  Germany            Burkina Faso       *p*
  ----------------------------------------------- ------------------ ------------------ -----------
  n =                                             20                 40                 
  Female \[n = \]                                 13 (65%)           18 (45%)           \-
  Age \[median, range\]                           28 (23-38)         27 (19-37)         0.68
  **Naive CD4^+^lymphocytes**                                                           
  CD45^bright^CCR7^+^\[% of CD4^+^lymphocytes\]   38 (16-60)         22 (3-48)          \< 0.0001
  **CD4^+^T-cell activation**                                                           
  CD95^+^\[% of CD4^+^T-cells J                   72 (57-100)        84 (50-97)         0.002
  CD95-ABC of CD4^+^CD95^dim^T-cells \[AUJ        108 (65-619)       26.3 (196-686)     \< 0.0001
  CD95-ABC of CD4^+^CD95^bright^T-cells \[AUJ     2996 (1655-5331)   3316 (1474-5285)   0.05
  **Naïve CD8^+^lymphocytes**                                                           
  CD45^bright^CCR7^+^\[% of CD8^+^lymphocytes\]   26 (6-53)          23 (5-52)          0.56
  **CD8^+^T-cell activation**                                                           
  CD38+ \[% of CD8^+^T-cells\]                    67 (56-97)         77 (35-99)         0.03
  CD38-ABC of CD8^+^CD38^+^T-cells \[AU\]         1384 (440-3270)    1560 (866-2450)    0.33

If not otherwise indicated, median values with 10^th^and 90^th^percentiles in parentheses are shown. The Mann-Whitney U-test was used to compare groups. Abbreviations: ABC = Antibody binding capacity, AU = arbitrary units.

Discussion
==========

Short-term stimulation of peripheral blood lymphocytes with the malaria antigen *Pf*MSP-1 allowed us to detect significant numbers of *Pf*MSP-1-specific CD4^+^lymphocytes in healthy HIV-1-negative blood donors in Nouna, Burkina Faso, but not in Heidelberg, Germany. Fourteen of 17 healthy blood donors in Nouna (82%) harboured cytokine producing *Pf*MSP-1-specific CD4^+^lymphocytes in their peripheral blood - a number quite similar to the 80% prevalence of antibodies against *Pf*MSP-1 observed in the local population (Coulibaly B, unpublished results). T-cell memory against *Plasmodium falciparum*is thus detectable for at least 6 months after the rainy season, i.e., after the period of high exposure to the parasite.

Naturally acquired T-cell responses to *Plasmodium falciparum*may shape the expression pattern of activation markers on peripheral blood CD4^+^T-cells from healthy adults in different ways. Direct involvement in the cellular immune response via T-cell receptor activation may lead to recruitment of naive CD4^+^T-cells into the effector memory or the central memory pool, thus increasing the percentage of CD4^+^CD95^bright^Tcells and causing a decrease in the percentage of CCR7^+^CD45RA^+^cells. Bystander activation of naïve CD4^+^T-cells due to intermittent high production of IFN-γ by P*f*MSP-1-specific CD4^+^lymphocytes may increase expression levels of CD95 especially on CD4^+^CD95^dim^bystander T-cells. When comparing healthy adults in Burkina Faso and Germany, all these parameters were significantly different between both groups. Our findings therefore indicate that naïve CD4^+^T-cells are more activated in healthy adult Burkinabe than in Germans. Differences in the exposure to *Plasmodium falciparum are*the most likely explanation for this phenomenon.

Skewed maturation and increased activation of peripheral blood T-cells could also be caused by exposure to other infectious diseases. We had observed high prevalences of, e.g., CMV and HBV in the study area [@B8]. However, T-cell responses to viral infection would be expected to involve primarily the CD8^+^T-cell compartment [@B14]. The differences in markers of CD8^+^T-cell maturation and activation between healthy adults in Burkina Faso and Germany were characterized only by a slightly higher percentage of CD38^+^CD8^+^T-cells in Burkinabe. Differences in the exposure to viral infections are therefore an unlikely cause of the deviations observed in the CD4^+^T-cell compartment in these individuals.

We had previously shown that elevated CD95 expression levels on cD4^+^CD95^dim^T-cells in HIV-1-infected children and adolescents were not necessarily leading to increased CD95-induced apoptosis of these cells *in vitro*[@B3]. It is not known, whether increased CD95 expression alters other functional T-cell properties. The CD95 signaling cascade has pleiotropic effects on these cells. While high signal intensities may silence T-cell receptor-induced activation (anergy) or cause activation-induced cell death (apoptosis), low signal intensities especially in resting T-cells may exert co-stimulatory effects [@B18]. Stronger early IFN-γ responses against *Plasmodium falciparum*have been correlated with lower susceptibility to parasitemia in an interethnic comparison in Mali [@B13]. The molecular mechanism which mediates this effect has not yet been discovered. The IFN-γ-induced increase in expression levels of CD95 on CD4^+^lymphocytes observed in our study may contribute to this effect by lowering the activation threshold of resting naïve CD4^+^T-cells.
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